Search Results

There are 22748 results for: content related to: A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  2. Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease

    European Journal of Neurology

    Volume 20, Issue 2, February 2013, Pages: 271–280, A. H. V. Schapira, F. Stocchi, R. Borgohain, M. Onofrj, M. Bhatt, P. Lorenzana, V. Lucini, R. Giuliani, R. Anand and The Study 017 Investigators

    Version of Record online : 12 SEP 2012, DOI: 10.1111/j.1468-1331.2012.03840.x

  3. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  4. You have full text access to this OnlineOpen article
    Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations

    Movement Disorders

    Volume 29, Issue 2, February 2014, Pages: 229–237, Rupam Borgohain, J. Szasz, P. Stanzione, C. Meshram, M. Bhatt, D. Chirilineau, F. Stocchi, V. Lucini, R. Giuliani, E. Forrest, P. Rice, R. Anand and for the Study 016 Investigators

    Version of Record online : 9 DEC 2013, DOI: 10.1002/mds.25751

  5. You have full text access to this OnlineOpen article
    Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease

    Movement Disorders

    Volume 29, Issue 10, September 2014, Pages: 1273–1280, Rupam Borgohain, Jozsef Szasz, Paolo Stanzione, Chandrashekhar Meshram, Mohit H. Bhatt, Dana Chirilineau, Fabrizio Stocchi, Valentina Lucini, Rodolfo Giuliani, Emma Forrest, Patricia Rice, Ravi Anand and the Study 018 Investigators

    Version of Record online : 10 JUL 2014, DOI: 10.1002/mds.25961

  6. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  7. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Version of Record online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Version of Record online: 10 NOV 2010

  8. You have free access to this content
    The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical Trial

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 4, October 2012, Pages: 450–457, A Marquet, K Kupas, A Johne, B Astruc, A Patat, S Krösser and A Kovar

    Version of Record online : 5 SEP 2012, DOI: 10.1038/clpt.2012.128

  9. You have full text access to this OnlineOpen article
    Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease

    Pharmacology Research & Perspectives

    Volume 4, Issue 5, October 2016, Luca Loprete, Chiara Leuratti, Carlo Cattaneo, Mita M. Thapar, Colm Farrell and Marco Sardina

    Version of Record online : 8 AUG 2016, DOI: 10.1002/prp2.251

  10. 1-[2-(4-Benzyloxyphenoxy)Ethyl]Imidazole inhibits monoamine oxidase B and protects against neuronal loss and behavioral impairment in rodent models of Parkinson's disease

    Journal of Neuroscience Research

    Volume 93, Issue 8, August 2015, Pages: 1267–1278, Jin Yong Chung, Ji Won Lee, Choon Ho Ryu, Hye Kyung Min, Yeo Jin Yoon, Mi Jung Lim and Cheol Hyoung Park

    Version of Record online : 24 FEB 2015, DOI: 10.1002/jnr.23577

  11. Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects

    Biopharmaceutics & Drug Disposition

    Volume 33, Issue 9, December 2012, Pages: 550–559, Sonja Krösser, Anne Marquet, Dieter Gallemann, Peter Wolna, Nicolas Fauchoux, Robert Hermann and Andreas Johne

    Version of Record online : 19 NOV 2012, DOI: 10.1002/bdd.1822

  12. Absolute Bioavailability and Effect of Food on the Disposition of Safinamide Immediate Release Tablets in Healthy Adult Subjects

    Clinical Pharmacology in Drug Development

    Volume 2, Issue 1, January 2013, Pages: 79–89, Annick Seithel-Keuth, Andreas Johne, Achim Freisleben, Katrin Kupas, Michael Lissy and Sonja Krösser

    Version of Record online : 22 FEB 2013, DOI: 10.1002/cpdd.2

  13. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  14. Neuroprotection by safinamide in the 6-hydroxydopamine model of Parkinson's disease

    Neuropathology and Applied Neurobiology

    Volume 42, Issue 5, August 2016, Pages: 423–435, Mona Sadeghian, Gizem Mullali, Jennifer M. Pocock, Thomas Piers, Arthur Roach and Kenneth J. Smith

    Version of Record online : 25 SEP 2015, DOI: 10.1111/nan.12263

  15. New treatments for levodopa-induced motor complications

    Movement Disorders

    Volume 30, Issue 11, 15 September 2015, Pages: 1451–1460, Olivier Rascol, Santiago Perez-Lloret and Joaquim J Ferreira

    Version of Record online : 21 AUG 2015, DOI: 10.1002/mds.26362

  16. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Version of Record online : 24 APR 2007, DOI: 10.1002/mds.21535

  17. You have free access to this content
    Randomized placebo-controlled trial of zonisamide in patients with Parkinson's disease

    Neurology and Clinical Neuroscience

    Volume 4, Issue 1, January 2016, Pages: 10–15, Miho Murata, Kazuko Hasegawa, Ichiro Kanazawa, Kenji Shirakura, Kenji Kochi, Rieko Shimazu and The Zonisamide PD Study Group

    Version of Record online : 20 AUG 2015, DOI: 10.1111/ncn3.12026

  18. Parkinson's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt084

  19. Abstracts

    Movement Disorders

    Volume 31, Issue S1, March 2016, Pages: S12–S100,

    Version of Record online : 10 MAR 2016, DOI: 10.1002/mds.26576

  20. You have free access to this content
    Comparison of ropinirole controlled- and immediate-release in Japanese patients with advanced Parkinson's disease

    Neurology and Clinical Neuroscience

    Volume 3, Issue 1, January 2015, Pages: 18–24, Nobutaka Hattori, Hiroshi Nishioka, Kazuko Hasegawa and on behalf of the SWAN Study Investigators

    Version of Record online : 25 NOV 2014, DOI: 10.1111/ncn3.128